Contrasting ZimVie (NASDAQ:ZIMV) & Straumann (OTCMKTS:SAUHY)
ZimVie (NASDAQ:ZIMV – Get Free Report) and Straumann (OTCMKTS:SAUHY – Get Free Report) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, valuation, institutional ownership, dividends, analyst recommendations, risk and earnings. Risk & Volatility ZimVie has a beta of 2.31, indicating […]
More Stories
Analysts Set Brookfield Asset Management Ltd. (NYSE:BAM) PT at $53.88
Brookfield Asset Management Ltd. (NYSE:BAM – Get Free Report) (TSE:BAM.A) has earned an average rating of “Hold” from the thirteen...
Semtech Co. (NASDAQ:SMTC) Given Consensus Rating of “Moderate Buy” by Analysts
Shares of Semtech Co. (NASDAQ:SMTC – Get Free Report) have been given a consensus rating of “Moderate Buy” by the...
The Cigna Group (NYSE:CI) Given Average Rating of “Buy” by Brokerages
The Cigna Group (NYSE:CI – Get Free Report) has received an average rating of “Buy” from the fifteen ratings firms...
Red Rock Resorts Amends Credit Agreement, Reducing Interest Rates
Red Rock Resorts, Inc. (NASDAQ:RRR) reported today the entry into an agreement that significantly impacts its financial structure. On December...
Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Receives $42.33 Average PT from Analysts
Edgewise Therapeutics, Inc. (NASDAQ:EWTX – Get Free Report) has received a consensus rating of “Buy” from the six ratings firms...
Astrana Health, Inc. (NASDAQ:ASTH) Receives Consensus Rating of “Moderate Buy” from Analysts
Shares of Astrana Health, Inc. (NASDAQ:ASTH – Get Free Report) have earned an average rating of “Moderate Buy” from the...